Failure of Urinary and Serum Hepatocyte Growth Factor Assay as an Early Marker of Diabetic Nephropathy

Publisher： Karger

E-ISSN： 2235-3186|82|4|365-365

ISSN： 1660-8151

Source： Nephron, Vol.82, Iss.4, 1999-08, pp. : 365-365

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Utility of Serum and Urinary Transforming Growth Factor-Beta Levels as Markers of Diabetic Nephropathy

By  

Nephron, Vol. 86, Iss. 2, 2000-09 ,pp. : 234-235

Karger

Access to resources Recommend Favorite

Usefulness of a Highly Sensitive Urinary and Serum IL-6 Assay in Patients with Diabetic Nephropathy

By  

Nephron, Vol. 85, Iss. 1, 2000-04 ,pp. : 81-85

Karger

Access to resources Recommend Favorite

Increased Excretion of Urinary Transforming Growth Factor Beta 1 in Patients with Diabetic Nephropathy

By  

American Journal of Nephrology, Vol. 18, Iss. 6, 1998-12 ,pp. : 490-494

Karger

Access to resources Recommend Favorite

Vascular Endothelial Growth Factor in Diabetic Nephropathy

By  

Kidney and Blood Pressure Research, Vol. 26, Iss. 5-6, 2003-11 ,pp. : 338-343

Karger

Access to resources Recommend Favorite

Serum Hepatocyte Growth Factor Levels in Patients with Renal Diseases

By  

American Journal of Nephrology, Vol. 19, Iss. 4, 1999-08 ,pp. : 509-512

Karger

Access to resources Recommend Favorite